Deferoxamine: Clinical Trials

9 trials of Deferoxamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 3 completed, 1 recruiting. 9 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Unknown 5, Completed 3, Recruiting 1
Phase 24Unknown 4

Follow Deferoxamine: new trials by email Literature Review of Deferoxamine trials Research Report on Deferoxamine

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial
Deferoxamine, placebo - Intracranial Aneurysm, Subarachnoid Hemorrhage
Phase 1 / Phase 2UnknownRadboud University Medical Center402022-12-022023-04-24
Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.
Antioxidant therapy, NaCl 0.9% - Acute Myocardial Infarction, Ischemia-reperfusion Injury
Phase 1CompletedUniversity of Chile182022-08-092024-01-12
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
Deferoxamine (DFO) - Leptomeningeal Metastases
Phase 1RecruitingMemorial Sloan Kettering Cancer Center322021-12-222026-11-18
Application of Desferal to Treat COVID-19
Deferoxamine - COVID-19
Phase 1 / Phase 2UnknownKermanshah University of Medical Sciences502020-04-012020-05-04
The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma
Conventional TACE, Deferoxamine and conventional TACE - Hepatocellular Carcinoma Non-resectable
Phase 1UnknownJinan Military General Hospital1002018-09-012019-02-22
Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage
deferoxamine, Xingnaojing injection, Normal saline - Intracerebral Hemorrhage
Phase 1 / Phase 2UnknownCapital Medical University1802015-03-012015-05-18
Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major
Desferrioxamine, LegalonĀ® (Silymarin), Silymarin (Legalon) - Immune Abnormalities
Phase 1CompletedShiraz University of Medical Sciences252012-06-012012-12-19
Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both
Deferoxamine, Deferasirox - Thalassemia
Phase 1 / Phase 2UnknownWeill Medical College of Cornell University62008-08-012010-11-05
Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage
Deferoxamine Mesylate - Intracerebral Hemorrhage
Phase 1CompletedBeth Israel Deaconess Medical Center202008-07-012018-01-16

Conditions studied

Cerebral Hemorrhage (2)  ·  COVID-19 (1)  ·  Intracranial Aneurysm (1)  ·  Intracranial Hemorrhages (1)  ·  Meningeal Carcinomatosis (1)  ·  Myocardial Reperfusion Injury (1)  ·  Recurrence (1)  ·  Reperfusion Injury (1)  ·  Stroke (1)  ·  Subarachnoid Hemorrhage (1)  ·  Thalassemia (1)  ·  beta-Thalassemia (1)

Sponsors

Beth Israel Deaconess Medical Center (1)  ·  Capital Medical University (1)  ·  Jinan Military General Hospital (1)  ·  Kermanshah University of Medical Sciences (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Radboud University Medical Center (1)  ·  Shiraz University of Medical Sciences (1)  ·  University of Chile (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (3)  ·  China (2)  ·  Iran (2)  ·  Chile (1)  ·  Netherlands (1)

Top investigators

Abraham IJ Gajardo, MD, PhD (1)  ·  Amir Kiani, PhD (1)  ·  Jeroen Boogaarts, M.D., Ph.D. (1)  ·  Jessica Wilcox, MD (1)  ·  Magdy Selim, MD, PhD (1)  ·  Maolin He, MD (1)  ·  Robert W Grady, Ph.D. (1)  ·  Yadollah Shakiba, MD, PhD (1)  ·  Zahra Amirghofran, PhD (1)

Results publications

PMID 10051178, PMID 10669330, PMID 11886437, PMID 1406879, PMID 16787239, PMID 18369153, PMID 18552864, PMID 22187937, PMID 22875626, PMID 25076907, PMID 25291189, PMID 28583206, PMID 29619244, PMID 29719970, PMID 33236783, PMID 38973337, PMID 7811060, PMID 8067783, PMID 8554902, PMID 8665150

NIH funding

R01NS057127 (1)